Literature DB >> 22551548

A prospective biological study in relation to a family with Li-Fraumeni syndrome.

Olaia Aurtenetxe Sáez1, Begoña Calvo, Ana Fernández-Teijeiro, Pedro Pérez, Aurora Navajas.   

Abstract

INTRODUCTION: The Li-Fraumeni syndrome (LFS) is an autosomal dominant hereditary disorder associated with different tumor types in childhood and young adults. Approximately 70% of LFS cases contain germline mutations in the TP53 gene. We report a case of a family suspected of LFS.
MATERIALS AND METHODS: The proband and four members of the family affected were diagnosed with cancer at an early age and they all died except the proband. Exons 5-9 from TP53 gene were analysed by direct amplification and sequencing in 7 family members.
RESULTS: The analysis revealed a germline nonsense mutation in exon 8 at codon 306 of the codified region of the TP53 gene, causing a change of CGA to TGA (Arg→Stop) in the proband, her mother, her cousin and her maternal uncle. Proband's maternal grandmother and aunt do not have the mutation.
CONCLUSIONS: The members of this family that were studied meet the criteria of classic LFS and the described mutation increases their susceptibility to develop cancer. The proband's maternal grandfather died of lung cancer in 1993, and we believe that he was the carrier of the mutation in this family.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22551548     DOI: 10.1007/s12094-012-0815-1

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  13 in total

1.  Mutation spectrum of the p53 gene in bone and soft tissue sarcomas.

Authors:  J Toguchida; T Yamaguchi; B Ritchie; R L Beauchamp; S H Dayton; G E Herrera; T Yamamuro; Y Kotoura; M S Sasaki; J B Little
Journal:  Cancer Res       Date:  1992-11-15       Impact factor: 12.701

2.  Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients.

Authors:  E D Lustbader; W R Williams; M L Bondy; S Strom; L C Strong
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

Review 3.  Assessing TP53 status in human tumours to evaluate clinical outcome.

Authors:  T Soussi; C Béroud
Journal:  Nat Rev Cancer       Date:  2001-12       Impact factor: 60.716

4.  Prospective study of a family cancer syndrome.

Authors:  F P Li; J F Fraumeni
Journal:  JAMA       Date:  1982-05-21       Impact factor: 56.272

Review 5.  Germline TP53 mutations and Li-Fraumeni syndrome.

Authors:  J M Varley
Journal:  Hum Mutat       Date:  2003-03       Impact factor: 4.878

6.  ARCAD: a method for estimating age-dependent disease risk associated with mutation carrier status from family data.

Authors:  C Le Bihan; C Moutou; L Brugières; J Feunteun; C Bonaïti-Pellié
Journal:  Genet Epidemiol       Date:  1995       Impact factor: 2.135

Review 7.  Genetic testing for cancer predisposition.

Authors:  C Eng; H Hampel; A de la Chapelle
Journal:  Annu Rev Med       Date:  2001       Impact factor: 13.739

8.  Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome.

Authors:  J M Birch; V Blair; A M Kelsey; D G Evans; M Harris; K J Tricker; J M Varley
Journal:  Oncogene       Date:  1998-09-03       Impact factor: 9.867

9.  Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome.

Authors:  T Frebourg; N Barbier; Y X Yan; J E Garber; M Dreyfus; J Fraumeni; F P Li; S H Friend
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

10.  Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.

Authors:  Magali Olivier; David E Goldgar; Nayanta Sodha; Hiroko Ohgaki; Paul Kleihues; Pierre Hainaut; Rosalind A Eeles
Journal:  Cancer Res       Date:  2003-10-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.